DOXY-LEMMON Drug Patent Profile
✉ Email this page to a colleague
When do Doxy-lemmon patents expire, and what generic alternatives are available?
Doxy-lemmon is a drug marketed by Teva and is included in two NDAs.
The generic ingredient in DOXY-LEMMON is doxycycline hyclate. There are twenty-eight drug master file entries for this compound. Seventy-four suppliers are listed for this compound. Additional details are available on the doxycycline hyclate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Doxy-lemmon
A generic version of DOXY-LEMMON was approved as doxycycline hyclate by CARIBE HOLDINGS on November 8th, 1982.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for DOXY-LEMMON?
- What are the global sales for DOXY-LEMMON?
- What is Average Wholesale Price for DOXY-LEMMON?
Summary for DOXY-LEMMON
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 2 |
| Raw Ingredient (Bulk) Api Vendors: | 55 |
| Patent Applications: | 438 |
| DailyMed Link: | DOXY-LEMMON at DailyMed |
US Patents and Regulatory Information for DOXY-LEMMON
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Teva | DOXY-LEMMON | doxycycline hyclate | CAPSULE;ORAL | 062497-001 | Aug 23, 1984 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Teva | DOXY-LEMMON | doxycycline hyclate | CAPSULE;ORAL | 062497-002 | Jun 15, 1984 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Teva | DOXY-LEMMON | doxycycline hyclate | TABLET;ORAL | 062581-001 | Mar 15, 1985 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
